14-day Premium Trial Subscription Sign Up For FreeGet Free
Nasdaq - Total Crash or Bounce-Up? Click To Watch.

BiondVax Pharmaceuticals Ltd. Stock Forecast

NASDAQ:BVXV Open a Brokerage Account

$0.73 (10.62%)

Volume: 227.7k

Closed: Sep 30, 2022

Hollow Logo Score: -3.828

BiondVax Pharmaceuticals Ltd. Stock Forecast

$0.73 (10.62%)

Volume: 227.7k

Closed: Sep 30, 2022

Score Hollow Logo -3.828

BiondVax Pharmaceuticals Ltd. Company Profile

Jerusalem BioPark Building, 2nd floor Hadassah Ein Kerem Campus

Jerusalem 7403618

972 8 930 2529

www.biondvax.com

Industry: Biotechnology

Sector: Healthcare

BiondVax Pharmaceuticals Ltd.

Description

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Hot Stocks To Watch:

About BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development ... BVXV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT